BTIG analyst Justin Zelin reiterated a Buy rating and $91.00 price target on Immunocore Holdings (NASDAQ: IMCR)The analyst comments "IMCR ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE